Centum Electronics (517544) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
5 Nov, 2026Executive summary
Q2 standalone revenue was Rs 3,118.19 million, up 52% YoY; EBITDA rose 63% to Rs 396 million and PAT rose 77% to Rs 228.12 million.
Order book reached Rs 19.5 billion at September 30, 2026, up 38% YoY; adjusted ROCE was 21% in H1 FY27.
H1 consolidated PAT of Rs 1,284.77 million included discontinued-operation earnings and an Rs 812.33 million deconsolidation gain; continuing-operations PAT was Rs 341.58 million.
Proposed increase in borrowing limits from Rs 500 crore to Rs 1,000 crore is subject to shareholder approval.
Financial highlights
H1 standalone revenue was Rs 5,159.18 million; PAT was Rs 363.45 million, up 32% and 28% YoY, respectively.
Q2 standalone EBITDA margin was 12.69%, up 87 bps YoY; PAT margin was 7.31%, up 103 bps.
H1 standalone EBITDA margin was 12.11%, down 72 bps YoY; PAT margin was 7.02%, down 25 bps.
H1 consolidated revenue rose 37.5% to Rs 5,162 million; EBITDA grew 15.8% to Rs 632 million, with margin down 231 bps to 12.24%.
Outlook and guidance
Medium-term revenue growth objective remains 25%-30%; management expressed confidence, with growth potentially closer to 30%, but gave no specific short-term guidance.
Combined margin range is 12.5%-13%; targets are 13% next year and 14%-15% over three to four years.
BTS margins are expected at 20%-22%; management expects stronger BTS execution in H2 than H1, while noting quarterly variation.
Semiconductor EMS opportunity is expected to reach $45-$50 million annually within ~two years, exceeding the earlier $25-$30 million estimate and led mainly by the anchor customer.
Latest events from Centum Electronics
- Adjusted revenue grew 7%; H2 BTS deliveries are expected to support recovery.517544
Q1 24/25 - FY25 targets rely on a stronger H2 led by BTS delivery and subsidiary performance.517544
Q2 24/25 - Ausar provision and Canadian losses weighed on consolidated results despite standalone growth.517544
Q3 24/25 - Q4 margins rebounded as the order book supported FY26 growth targets despite subsidiary losses.517544
Q4 24/25 - Revenue and margins improved YoY, while subsidiary losses and ER&D delays persist.517544
Q1 25/26 - Standalone growth strengthened, while subsidiary losses constrained consolidated margins.517544
Q2 25/26 - Standalone growth and defense prospects offset overseas restructuring losses and impairments.517544
Q3 25/26 - Revenue and order growth were offset by overseas restructuring losses.517544
Q4 25/26 - Order book rose 31% as Q1 margins softened and reported profit included discontinued operations.517544
Q1 26/27